Inhaled Vancomycin ( DrugBank: Vancomycin )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
299	Cystic fibrosis	2

299. Cystic fibrosis

---

Clinical trials : 1,695 /  Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01594827 (ClinicalTrials.gov)	October 2012	7/5/2012	Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)	Persistent MRSA Eradication Protocol (PMEP)	Cystic Fibrosis	Drug: Inhaled Vancomycin;Drug: Placebo (Sterile Water);Drug: Rifampin;Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX);Drug: Doxycycline;Drug: Mupirocin Intranasal Creme;Drug: 4% chlorhexidine gluconate liquid skin cleanser	Johns Hopkins University	Case Western Reserve University;Cystic Fibrosis Foundation	Completed	12 Years	N/A	All	29	Phase 2	United States
2	NCT01537666 (ClinicalTrials.gov)	November 2011	17/2/2012	Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics	Phase I, Reference-controlled, Dose Escalating Study to Examine the Pharmacokinetics and Safety of AeroVanc Inhalation Powder.	Healthy;Cystic Fibrosis	Drug: AeroVanc;Drug: IV vancomycin hydrochloride	Savara Inc.	INC Research Limited	Completed	18 Years	50 Years	All	25	Phase 1	Australia